|
|
|
|
EFFECTIVENESS OF LONG-ACTING ART WITH
CABOTEGRAVIR/RILPIVIRINE IN THE ICONA COHORT
|
|
|
Glasgow 2024 Nov 15-19
R. Gagliardini*1, S. De Benedittis2, A. Tavelli2,3, G. Lapadula4, V. Mazzotta1, E. Bruzzesi5, A. Cervo6, G. Carrozzo7, A. Saracino8, S. Rusconi9, G. Marchetti10, F. Ceccherini-
Silberstein11, A. Antinori1, A. d'Arminio Monforte2, C. Muccini5 on behalf of Icona Foundation Study Group.
|
|
|
|
|
|
|